Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.

about

Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.

Item

http://www.wikidata.org/entity/Q38902112

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Potentially life-threatening c ...... tic stem-cell transplantation.

@en

type

Item

label

Potentially life-threatening c ...... tic stem-cell transplantation.

@en

prefLabel

Potentially life-threatening c ...... tic stem-cell transplantation.

@en

P1476

Potentially life-threatening c ...... etic stem-cell transplantation

@en

P2093

Akitaka Nomura

http://www.w3.org/2001/XMLSchema#string

Keiji Nogami

http://www.w3.org/2001/XMLSchema#string

Midori Shima

http://www.w3.org/2001/XMLSchema#string

Satoshi Ochi

http://www.w3.org/2001/XMLSchema#string

Tomoko Matsumoto

http://www.w3.org/2001/XMLSchema#string

Yasufumi Takeshita

http://www.w3.org/2001/XMLSchema#string

P2860

Classifying types of disseminated intravascular coagulation: clinical and animal models

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.

Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation

Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.

P2888

s12185-017-2213-5

P304

126-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-017-2213-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Takashi Ishihara

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084034353

http://www.w3.org/2001/XMLSchema#string

P698

28303518

http://www.w3.org/2001/XMLSchema#string